SCHEMBL20095952

SCHEMBL20095952

CN(C)C1CCC=C(c2cccc(Br)c2)C1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.39
HTR2C P28335 4/20 0.39
HTR2B P41595 4/20 0.39
HRH3 Q9Y5N1 4/20 0.39
HTR1A P08908 8/20 0.37
HTR7 P34969 8/20 0.37
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
SLC6A4 P31645 1/20 0.34
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20095951 1.00 HTR2A (0.39) HTR2AHTR2CHTR2BHRH3HTR1A
SCHEMBL21311611 0.84 NISCH (0.40) HTR1AHTR7CHRNB4CHRNA3SLC6A4
SCHEMBL21311610 0.84 NISCH (0.40) HTR1AHTR7CHRNB4CHRNA3SLC6A4
SCHEMBL20096267 0.82 HTR1A (0.53) HTR2AHTR2CHTR2BHRH3HTR1A
SCHEMBL20096018 0.82 HTR1A (0.53) HTR2AHTR2CHTR2BHRH3HTR1A
SCHEMBL20095688 0.81 HTR2C (0.39) HTR2AHTR2CHTR2BHRH3HTR1A
SCHEMBL20095694 0.81 HTR2C (0.39) HTR2AHTR2CHTR2BHRH3HTR1A
SCHEMBL21312016 0.80 RAB9A (0.40) HRH3GABRG2GABRB3GABRA5GABRA3
SCHEMBL20096104 0.80 HTR1A (0.55) HTR2AHTR2CHTR2BHRH3HTR1A
SCHEMBL5198483 0.77 SLC6A4 (0.53) HTR2AHTR2CHTR2BHRH3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019165290-A1 PYRIDINE-SULFONAMIDE COMPOUNDS AND THEIR USE AGAINST PAIN AND RELATED CONDITIONS GENENTECH, INC. (US) 2019-08-29 WO disclosed
WO-2018072602-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2018-04-26 WO disclosed